/PRNewswire/ This week, Aspen Neuroscience will present to the Parkinson s community at the Future of Parkinson s Disease conference, held November 30 –.
/PRNewswire/ Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application,.
Research Optimizes Patient-Specific Stem Cell-Based Therapy for Parkinson s miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Study optimizes patient-specific stem cell-based therapy for Parkinson s disease medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ On Wednesday at the 2023 World Parkinson Congress in Barcelona, Aspen Neuroscience co-founder Andres Bratt-Leal, PhD, Senior Vice President.